The relationship of patent foramen ovale location with severity of stroke: A new risk factor for paradoxical embolism

References

• Cruz-González I, Solis J, Inglessis-Azuaje I, Palacios IF. Patent foramen ovale: current state of the art. Rev Esp Cardiol (Engl Ed). 2008;61:738–751.10.1157/13123995
   Web of Science ®Google Scholar
• Mattle HP, Meier B, Nedeltchev K. Prevention of stroke in patients with patent foramen ovale. Int J Stroke. 2010;5:92–102.10.1111/(ISSN)1747-4949
   PubMed Web of Science ®Google Scholar
• Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:17–20.10.1016/S0025-6196(12)60336-X
   PubMed Web of Science ®Google Scholar
• Almekhlafi MA, Wilton SB, Rabi DM, Ghali WA, Lorenzetti DL, Hill MD. Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis. Neurology. 2009;73:89–97.10.1212/WNL.0b013e3181aa2a19
   PubMed Web of Science ®Google Scholar
• Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS stroke data bank. Ann Neurol. 1989;25:382–390.10.1002/(ISSN)1531-8249
   PubMed Web of Science ®Google Scholar
• Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology. 2000;55:1172–1179.10.1212/WNL.55.8.1172
   PubMed Web of Science ®Google Scholar
• Alsheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke. 2009;40:2349–2355.10.1161/STROKEAHA.109.547828
   PubMed Web of Science ®Google Scholar
• Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318:1148–1152.10.1056/NEJM198805053181802
   PubMed Web of Science ®Google Scholar
• Thaler DE, Wahl A. Critique of closure or medical therapy for cryptogenic stroke with patent foramen ovale: the hole truth? Stroke. 2012;43:3147–3149.10.1161/STROKEAHA.112.659599
   PubMed Web of Science ®Google Scholar
• Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation. 2005;112:1063–1072.10.1161/CIRCULATIONAHA.104.524371
   PubMed Web of Science ®Google Scholar
• Calvet D, Mas JL. Closure of patent foramen ovale in cryptogenic stroke. Curr Opin Neurol. 2014;27:13–19.10.1097/WCO.0000000000000052
   PubMed Web of Science ®Google Scholar
• Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol. 2001;38:613–623.10.1016/S0735-1097(01)01427-9
   PubMed Web of Science ®Google Scholar
• Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke. 1995;26:1471–1477.
   PubMed Web of Science ®Google Scholar
• Wöhrle J. Closure of patent foramen ovale after cryptogenic stroke. The Lancet. 2006;368:350–352.10.1016/S0140-6736(06)69087-9
   PubMed Web of Science ®Google Scholar
• Khairy P, O’Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli. Ann Intern Med. 2003;139:753–760.10.7326/0003-4819-139-9-200311040-00010
   PubMed Web of Science ®Google Scholar
• Verma SK, Tobis JM. Explantation of patent foramen ovale closure devices. JACC Cardiovasc Interv. 2011;4:579–585.10.1016/j.jcin.2011.01.009
   PubMed Web of Science ®Google Scholar
• Yared K, Baggish AL, Solis J, et al. Echocardiographic assessment of percutaneous patent foramen ovale and atrial septal defect closure complications. Circ Cardiovasc Imaging. 2009;2:141–149.10.1161/CIRCIMAGING.108.832436
   PubMed Web of Science ®Google Scholar
• Latson LA, Jones TK, Jacobson J, Zahn E, Rhodes JF. Analysis of factors related to successful transcatheter closure of secundum atrial septal defects using the HELEX septal occluder. Am Heart J. 2006;151:1129–1211.
   PubMed Web of Science ®Google Scholar
• Thaman R, Faganello G, Gimeno JR, et al. Efficacy of percutaneous closure of patent foramen ovale: comparison among three commonly used occluders. Heart. 2011;97:394–399.10.1136/hrt.2010.203950
   PubMed Web of Science ®Google Scholar
• Chen L, Luo S, Yan L, Zhao W. A systematic review of closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and cryptogenic stroke or transient ischemic attack. J Neurol Sci. 2014;337:3–7.10.1016/j.jns.2013.11.027
   PubMed Web of Science ®Google Scholar
• Kitsios GD, Dahabreh IJ, Abu Dabrh AM, Thaler DE, Kent DM. Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence. Stroke. 2012;43:422–431.10.1161/STROKEAHA.111.631648
   PubMed Web of Science ®Google Scholar
• Agarwal S, Bajaj NS, Kumbhani DJ, Tuzcu EM, Kapadia SR. Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism. JACC Cardiovasc Interv. 2012;5:777–789.10.1016/j.jcin.2012.02.021
   PubMed Web of Science ®Google Scholar
• Fathi AR, Eshtehardi P, Meier B. Patent foramen ovale and neurosurgery in sitting position: a systematic review. Br J Anaesth. 2009;102:588–596.10.1093/bja/aep063
   PubMed Web of Science ®Google Scholar
• Windecker S, Wahl A, Nedeltchev K, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol. 2004;44:750–758.10.1016/j.jacc.2004.05.044
   PubMed Web of Science ®Google Scholar
• Wahl A, Juni P, Mono ML, et al. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Circulation. 2012;125:803–812.10.1161/CIRCULATIONAHA.111.030494
   PubMed Web of Science ®Google Scholar
• Mirzada N, ladenvall P, Hansson PO, Eriksson P, Dellborg M. Multidisciplinary management of patent foramen ovale (PFO) and cryptogenic stroke/TIA. J Multidiscip Healthc. 2013;6:357–363.10.2147/JMDH
   PubMedGoogle Scholar
• Hakeem A, Marmagkiolis K, Hacioglu Y, et al. Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: comprehensive systematic review and meta-analysis of randomized controlled trials. Cardiovasc Revasc Med. 2013;14:349–355.10.1016/j.carrev.2013.08.010
   PubMedGoogle Scholar
• Henderson RA, Bath PM. Is closure of patent foramen ovale to prevent ischaemic stroke ever justified? BMJ. 2013;347:f6193.10.1136/bmj.f6193
   Google Scholar
• Netter FH. Anatomy and physiology. In: Brass A, editor. Hearth, the netter collection of medical ıllustrations heart volume 5: part I. Philadelphia, PA: Elsevier Saunders; 2007. p. 110–154.
   Google Scholar
• Yasunaga D, Hamon M. MDCT of interatrial septum. Diagn Interv Imaging. 2015;96:891–899.10.1016/j.diii.2015.02.011
   PubMed Web of Science ®Google Scholar
• Kim YJ, Hur J, Shim C-Y, Lee H-J, Ha J-W, Choe KO, et al. Patent foramen ovale: diagnosis with multidetector CT-comparison with transesophageal echocardiography. Radiology. 2009;250:61–67.10.1148/radiol.2501080559
   PubMed Web of Science ®Google Scholar